# LRRK2

## Overview
The LRRK2 gene encodes the protein leucine-rich repeat kinase 2, a multi-domain kinase that plays a pivotal role in various cellular processes, including autophagy, mitochondrial dynamics, and immune function. As a member of the ROCO protein family, LRRK2 is characterized by its complex structure, which includes domains such as ankyrin repeats, leucine-rich repeats, a Ras of complex proteins (ROC) GTPase domain, a C-terminal of ROC (COR) domain, a kinase domain, and WD40 repeats (Berwick2019LRRK2; Myasnikov2021Structural). The protein's kinase activity is crucial for phosphorylating Rab GTPase family members, influencing vesicle trafficking and intracellular transport (Zhang2023LRRK2). Mutations in the LRRK2 gene are notably linked to Parkinson's disease, where they contribute to neurodegeneration through a toxic gain-of-function mechanism (Kestenbaum2017Clinical). Additionally, LRRK2's involvement in immune pathways underscores its broader significance in diseases beyond neurodegeneration, such as Crohn's disease (Kestenbaum2017Clinical).

## Structure
The LRRK2 protein is a large, multidomain structure with significant implications in Parkinson's disease. It consists of several key domains: an ankyrin repeat (ANK) domain, a leucine-rich repeat (LRR) domain, a Ras of complex proteins (ROC) GTPase domain, a C-terminal of ROC (COR) domain, a kinase domain, and WD40 repeats (Berwick2019LRRK2; Myasnikov2021Structural). The ROC and COR domains form a functional tandem known as the RocCOR domain, which is crucial for its GTPase activity (Berwick2019LRRK2).

The protein can exist in monomeric, dimeric, or filamentous forms, with dimerization being a key feature for its activation (Zhang2023LRRK2; Myasnikov2021Structural). The kinase domain is involved in phosphorylating Rab GTPase family members and is typically found in an inactive conformation, although mutations can increase its activity (Zhang2023LRRK2; Myasnikov2021Structural). The WD40 domain interacts with the N-terminal domains, acting as a regulatory 'brake' (Zhang2023LRRK2).

LRRK2 is primarily cytosolic but can associate with intracellular membranes and microtubules, with its interaction enhanced by Parkinson's disease-linked mutations (Leschziner2021Structural). The protein's structure facilitates its role in phosphorylation and protein-protein interactions, with common post-translational modifications including phosphorylation (Zhang2023LRRK2).

## Function
LRRK2 (leucine-rich repeat kinase 2) is a multi-domain protein involved in several critical cellular processes. It plays a significant role in autophagy, particularly macroautophagy, which is essential for cellular homeostasis by degrading unwanted cellular components. LRRK2's involvement in autophagy is complex and varies across different cell types, with its activity modulated by factors such as mTOR signaling (Berwick2019LRRK2).

In the context of synaptic vesicle trafficking, LRRK2 interacts with proteins like Rab5B and endophilinA, influencing processes such as endocytosis and macroautophagy (Seol2019Rab). It also regulates protein synthesis by phosphorylating regulators like eIF4E-BP and ribosomal proteins, affecting both cap-dependent and -independent translations (Seol2019Rab).

LRRK2 is involved in mitochondrial dynamics, interacting with proteins such as Dlp1/Drp1 to regulate mitochondrial fission (Seol2019Rab). It is recruited to the mitochondrial outer membrane in response to mitochondrial depolarization, facilitating the removal of damaged mitochondria through mitophagy (Berwick2019LRRK2).

LRRK2 is also implicated in immune function, being highly expressed in immune cells and affecting processes like phagosome maturation and phagocytic activity (Seol2019Rab). Its activity is modulated by immune stimuli, such as TLR agonists, highlighting its role in immune responses (Seol2019Rab).

## Clinical Significance
Mutations in the LRRK2 gene are a significant cause of Parkinson's disease (PD), particularly in familial cases, where they follow an autosomal dominant pattern of inheritance. The G2019S mutation is the most common, found in both familial and sporadic PD cases, and is associated with late-onset PD (Kestenbaum2017Clinical). This mutation, along with others like R1441C, enhances LRRK2 kinase activity, suggesting a toxic gain-of-function mechanism that contributes to neurodegeneration (Kestenbaum2017Clinical; Li2014The).

LRRK2 mutations are linked to typical PD symptoms, including motor and non-motor manifestations, and are often indistinguishable from idiopathic PD (Kluss2019LRRK2). Neuropathological features include α-synuclein positive Lewy bodies and phosphorylated tau aggregates (Kluss2019LRRK2). LRRK2 is also implicated in the autophagy-lysosomal pathway, with mutations causing autophagic stress and lysosomal dysfunction, which are critical in PD pathogenesis (Li2014The).

Beyond PD, LRRK2 is associated with other diseases, such as Crohn's disease, where a loss of function increases disease risk, indicating its role in immune homeostasis (Kestenbaum2017Clinical). The gene's involvement in inflammatory pathways and its potential link to other neurodegenerative diseases highlight its broader clinical significance (Kestenbaum2017Clinical).

## Interactions
LRRK2 (leucine-rich repeat kinase 2) is a multi-domain protein that engages in numerous protein-protein interactions, playing a crucial role in various cellular processes. The Roc domain of LRRK2 serves as a significant hub for protein interactions, with approximately 85% of its interactors binding through this domain. These interactions are linked to processes such as endocytosis, autophagy, RNA metabolism, synaptic signaling, and cytoskeleton-associated processes (Cogo2022The).

LRRK2 interacts with cytoskeletal proteins, including tubulin and actin-regulating proteins like Arp2/3, and microtubule-binding proteins such as MAP1B. It also acts as a scaffold in MAPK and WNT signaling pathways, interacting with proteins like MKK3/6, JIP1-4, and Dishevelled proteins (DVL1-3) (Gloeckner2020GuiltbyAssociation). In the context of mitochondrial dynamics, LRRK2 interacts with dynamin-related GTPases, including Drp1, Mfn1, Mfn2, and OPA1, influencing mitochondrial fission and fusion (Stafa2013Functional).

The protein also binds to 14-3-3 proteins, which regulate its stability and activity, with interactions modulated by phosphorylation at specific sites (Reyniers2014Differential). LRRK2's interaction with Rab GTPases, such as Rab29, Rab8a, and Rab10, is crucial for its role in vesicle trafficking and intracellular transport (Cogo2022The). These interactions highlight LRRK2's involvement in cellular processes relevant to neurodegenerative diseases like Parkinson's disease.


## References


[1. (Zhang2023LRRK2) Xiaojuan Zhang and Arjan Kortholt. Lrrk2 structure-based activation mechanism and pathogenesis. Biomolecules, 13(4):612, March 2023. URL: http://dx.doi.org/10.3390/biom13040612, doi:10.3390/biom13040612. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom13040612)

[2. (Kluss2019LRRK2) Jillian H. Kluss, Adamantios Mamais, and Mark R. Cookson. Lrrk2 links genetic and sporadic parkinson’s disease. Biochemical Society Transactions, 47(2):651–661, March 2019. URL: http://dx.doi.org/10.1042/bst20180462, doi:10.1042/bst20180462. This article has 162 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bst20180462)

[3. (Seol2019Rab) Wongi Seol, Daleum Nam, and Ilhong Son. Rab gtpases as physiological substrates of lrrk2 kinase. Experimental Neurobiology, 28(2):134–145, April 2019. URL: http://dx.doi.org/10.5607/en.2019.28.2.134, doi:10.5607/en.2019.28.2.134. This article has 34 citations.](https://doi.org/10.5607/en.2019.28.2.134)

[4. (Gloeckner2020GuiltbyAssociation) Christian Johannes Gloeckner and Pablo Porras. Guilt-by-association – functional insights gained from studying the lrrk2 interactome. Frontiers in Neuroscience, May 2020. URL: http://dx.doi.org/10.3389/fnins.2020.00485, doi:10.3389/fnins.2020.00485. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnins.2020.00485)

[5. (Li2014The) Jie-Qiong Li, Lan Tan, and Jin-Tai Yu. The role of the lrrk2 gene in parkinsonism. Molecular Neurodegeneration, November 2014. URL: http://dx.doi.org/10.1186/1750-1326-9-47, doi:10.1186/1750-1326-9-47. This article has 183 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1750-1326-9-47)

[6. (Berwick2019LRRK2) Daniel C. Berwick, George R. Heaton, Sonia Azeggagh, and Kirsten Harvey. Lrrk2 biology from structure to dysfunction: research progresses, but the themes remain the same. Molecular Neurodegeneration, December 2019. URL: http://dx.doi.org/10.1186/s13024-019-0344-2, doi:10.1186/s13024-019-0344-2. This article has 117 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s13024-019-0344-2)

[7. (Leschziner2021Structural) Andres E. Leschziner and Samara L. Reck‐Peterson. Structural biology of <scp>lrrk2</scp> and its interaction with microtubules. Movement Disorders, 36(11):2494–2504, August 2021. URL: http://dx.doi.org/10.1002/mds.28755, doi:10.1002/mds.28755. This article has 12 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/mds.28755)

[8. (Stafa2013Functional) Klodjan Stafa, Elpida Tsika, Roger Moser, Alessandra Musso, Liliane Glauser, Amy Jones, Saskia Biskup, Yulan Xiong, Rina Bandopadhyay, Valina L. Dawson, Ted M. Dawson, and Darren J. Moore. Functional interaction of parkinson’s disease-associated lrrk2 with members of the dynamin gtpase superfamily. Human Molecular Genetics, 23(8):2055–2077, November 2013. URL: http://dx.doi.org/10.1093/hmg/ddt600, doi:10.1093/hmg/ddt600. This article has 107 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddt600)

[9. (Myasnikov2021Structural) Alexander Myasnikov, Hanwen Zhu, Patricia Hixson, Boer Xie, Kaiwen Yu, Aaron Pitre, Junmin Peng, and Ji Sun. Structural analysis of the full-length human lrrk2. Cell, 184(13):3519-3527.e10, June 2021. URL: http://dx.doi.org/10.1016/j.cell.2021.05.004, doi:10.1016/j.cell.2021.05.004. This article has 130 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2021.05.004)

[10. (Reyniers2014Differential) Lauran Reyniers, Maria Grazia Del Giudice, Laura Civiero, Elisa Belluzzi, Evy Lobbestael, Alexandra Beilina, Giorgio Arrigoni, Rita Derua, Etienne Waelkens, Yan Li, Claudia Crosio, Ciro Iaccarino, Mark R. Cookson, Veerle Baekelandt, Elisa Greggio, and Jean‐Marc Taymans. Differential protein–protein interactions of <scp>lrrk</scp>1 and <scp>lrrk</scp>2 indicate roles in distinct cellular signaling pathways. Journal of Neurochemistry, 131(2):239–250, July 2014. URL: http://dx.doi.org/10.1111/jnc.12798, doi:10.1111/jnc.12798. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/jnc.12798)

[11. (Kestenbaum2017Clinical) Meir Kestenbaum and Roy N. Alcalay. Clinical Features of LRRK2 Carriers with Parkinson’s Disease, pages 31–48. Springer International Publishing, 2017. URL: http://dx.doi.org/10.1007/978-3-319-49969-7_2, doi:10.1007/978-3-319-49969-7_2. This article has 38 citations.](https://doi.org/10.1007/978-3-319-49969-7_2)

[12. (Cogo2022The) Susanna Cogo, Franz Y. Ho, Elena Tosoni, James E. Tomkins, Isabella Tessari, Lucia Iannotta, Thomas J. Montine, Claudia Manzoni, Patrick A. Lewis, Luigi Bubacco, Marie-Christine Chartier Harlin, Jean-Marc Taymans, Arjan Kortholt, Jeremy Nichols, Laura Cendron, Laura Civiero, and Elisa Greggio. The roc domain of lrrk2 as a hub for protein-protein interactions: a focus on pak6 and its impact on rab phosphorylation. Brain Research, 1778:147781, March 2022. URL: http://dx.doi.org/10.1016/j.brainres.2022.147781, doi:10.1016/j.brainres.2022.147781. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.brainres.2022.147781)